Accuray Incorporated announced that data from a phase III, randomized controlled trial, TomoBreast, indicate post-surgery hypofractionated radiotherapy delivered with the TomoTherapy® System is superior...
Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers, announced that the Company will advance...
TDK Corporation announced that subsidiary TDK Ventures, Inc. has invested in green hydrogen company Verdagy to enhance the development and rapid commercialization of their...
Kinetic River Corp., a leader in development of advanced flow cytometry technology, announced the successful completion of a Phase II Small Business Innovation Research...
Frost & Sullivan's recent analysis finds that the drawbacks of traditional medical imaging platforms are driving the need for novel mobile medical imaging systems....
